SCHEMBL31466526

SCHEMBL31466526

Cc1cc(C2CCN(CCC3CCOCC3)CC2)nn1-c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ DRD2 P14416 5/20 0.40
▸ DRD3 P35462 4/20 0.40
▸ SIGMAR1 Q99720 8/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ TP53 P04637 1/20 0.40
▸ PKM P14618 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ TMEM97 Q5BJF2 1/20 0.40
▸ HTR2B P41595 1/20 0.39
▸ KCNJ6 P48051 2/20 0.39
▸ KCNJ3 P48549 2/20 0.39
▸ HTR1A P08908 1/20 0.38
▸ DRD4 P21917 1/20 0.38
▸ KCNH2 Q12809 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ HTR2A P28223 1/20 0.38
▸ ACHE P22303 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31465843 0.90 SIGMAR1 (0.47) SIGMAR1SMN1; SMN2NPC1LMNATP53
SCHEMBL31466156 0.89 HTR4 (0.42) DRD2DRD3SMN1; SMN2NPC1LMNA
SCHEMBL31466437 0.83 DRD2 (0.47) DRD2DRD3SIGMAR1TMEM97KCNH2
SCHEMBL31466615 0.79 SIGMAR1 (0.45) SIGMAR1SMN1; SMN2HTR2BKCNH2
SCHEMBL31465869 0.79 SIGMAR1 (0.52) DRD2SIGMAR1HTR2BKCNH2ACHE
SCHEMBL31466107 0.78 SIGMAR1 (0.44) DRD2SIGMAR1HTR2BKCNH2
SCHEMBL31465985 0.76 ABL1 (0.46) DRD2SIGMAR1HTR2BHTR1ADRD4
SCHEMBL31465980 0.74 SIGMAR1 (0.44) SIGMAR1HTR2BKCNH2
SCHEMBL31466142 0.71 DRD2 (0.43) DRD2DRD3SIGMAR1SMN1; SMN2RAB9A
SCHEMBL14686768 0.71 PRCP (0.57) DRD2DRD3SIGMAR1DRD4L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025049419-A1 PYRAZOLYL COMPOUNDS AS EMOPAMIL BINDING PROTEIN INHIBITORS GENZYME CORPORATION (US) 2025-03-06 — — WO disclosed
Send feedback